Megna Michael R bought KNSA
July 15, 2026 · Form 4 insider transaction
Megna Michael R bought 279 shares of Kiniksa Pharmaceuticals International, plc at $33.50 per share, a transaction worth $9.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 50 days after the transaction.
Direction
Acquired (buy-side)
Shares
279
Price
$33.50
Total value
$9.3K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateSeptember 3, 2026
Shares owned after27,697
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).